PMID- 7821892
OWN - NLM
STAT- MEDLINE
DCOM- 19950216
LR  - 20190821
IS  - 0309-0167 (Print)
IS  - 0309-0167 (Linking)
VI  - 25
IP  - 3
DP  - 1994 Sep
TI  - c-erbB-3 protein expression in human breast cancer: comparison with other tumour 
      variables and survival.
PG  - 247-52
AB  - c-erbB-3 protein expression was investigated immunohistochemically in a series of 
      97 malignant breast tumours using the monoclonal antibody RTJ1. Twenty-eight 
      cases (28.8%) showed c-erbB-3 overexpression, 31 cases (32%) showed normal levels 
      of c-erbB-3 and 38 cases (39.2%) were c-erbB-3 negative. c-erbB-3 overexpression 
      was positively but not significantly related to negative lymph node status and 
      survival over a 10-year follow-up period.
FAU - Quinn, C M
AU  - Quinn CM
AD  - Department of Histopathology, General Infirmary at Leeds, UK.
FAU - Ostrowski, J L
AU  - Ostrowski JL
FAU - Lane, S A
AU  - Lane SA
FAU - Loney, D P
AU  - Loney DP
FAU - Teasdale, J
AU  - Teasdale J
FAU - Benson, F A
AU  - Benson FA
LA  - eng
PT  - Journal Article
PL  - England
TA  - Histopathology
JT  - Histopathology
JID - 7704136
RN  - 0 (Proto-Oncogene Proteins)
RN  - EC 2.7.10.1 (ErbB Receptors)
RN  - EC 2.7.10.1 (Receptor, ErbB-3)
SB  - IM
MH  - Adult
MH  - Aged
MH  - Aged, 80 and over
MH  - Breast Neoplasms/mortality/*pathology
MH  - ErbB Receptors/*analysis
MH  - Female
MH  - Humans
MH  - Immunoenzyme Techniques
MH  - Middle Aged
MH  - Proto-Oncogene Proteins/*analysis
MH  - Receptor, ErbB-3
MH  - Survival Analysis
EDAT- 1994/09/01 00:00
MHDA- 1994/09/01 00:01
CRDT- 1994/09/01 00:00
PHST- 1994/09/01 00:00 [pubmed]
PHST- 1994/09/01 00:01 [medline]
PHST- 1994/09/01 00:00 [entrez]
AID - 10.1111/j.1365-2559.1994.tb01324.x [doi]
PST - ppublish
SO  - Histopathology. 1994 Sep;25(3):247-52. doi: 10.1111/j.1365-2559.1994.tb01324.x.